MRK
Stock Details
MRK is Merck & Co., Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 85.25$. Average daily volumn in 3 months 11.58M. Market cap 236.57B
Stock symbol : MRK. Exchange : NYSE. Currency : USD Lastest price : 93.55$. Total volume : 11.37M. Market state POSTPOST Click reload if you want to check the lastest price on market!!!
Merck & Co., Inc. (MRK)
Last Price
93.55$Change
1.46Volume
11.37M
| Previous Close | 92.09 |
| Open | 92.45 |
| Day Range | 92.45-94.08 |
| Bid | 93.35 x 900 |
| Ask | 93.97 x 1.4k |
| Volume | 11.37M |
| Average Volume | 11.58M |
| Market Cap | 236.57B |
| Beta | 0.37 |
| 52 Week Range | 70.89-94.56 |
| Trailing P/E | 16.74 |
| Foward P/E | 12.75 |
| Dividend (Yield %) | 2.95% |
| Ex-Dividend Date | 2022-03-14 |
Financial Details
Organization
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuti... cals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Market Cap:
236.57BRevenue:
48.7BTotal Assets:
105.69BTotal Cash:
8.1B
News about "Merck & Co., Inc."
CHMP Supports Approval Of Merck's Keytruda As Adjuvant In Post Surgery Melanoma Setting
Source from : YAHOO!Finance - 14 hours ago
European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending Merck & Co Inc (NYSE: MRK) Keytruda in melanoma setting. The opinion ...See details»
Merck KGaA (OTCMKTS:MKGAY) Given Consensus Rating of “Buy” by Analysts
Source from : Defense World - 13 hours ago
Merck KGaA (OTCMKTS:MKGAY – Get Rating) has been given an average recommendation of “Buy” by the seven brokerages that are covering the stock, MarketBeat reports. Three investment analysts have rated ...See details»
Merck accused of violating federal program by overcharging for drugs
Source from : The Business Journals - 4 days ago
The U.S. Health Resources and Services Administration sent Merck & Co. Inc. a letter last week, accusing the pharmaceutical giant of violating a federal program by overcharging for drugs. The program, ...See details»
Merck's blockbuster Keytruda gets EMA panel nod for expanded use in skin cancer
Source from : Seeking Alpha - 20 hours ago
The company said the CHMP's decision was backed by data from a phase 3 trial, dubbed KEYNOTE-716. Merck noted that if approved, Keytruda would be the first anti-PD-1 immunotherapy treatment option ...See details»
Merck (MRK) Shares Cross 3% Yield Mark
Source from : Nasdaq - 3 days ago
Looking at the universe of stocks we cover at Dividend Channel, in trading on Tuesday, shares of Merck & Co Inc (Symbol: MRK) were yielding above the 3% mark based on its quarterly dividend ...See details»
Merck & Company Inc. (MRK) Climbs to Annual-High Share Price
Source from : Digital Journal - 3 days ago
Merck & Company Inc. (NYSE:MRK) traded at a new 12-month high today of $91.79. Approximately 3.7 million shares have changed hands today, as compared to an average 30-day volume of 12 million shares.See details»
Merck Recognized for Responsible Entrepreneurship in the Netherlands
Source from : YAHOO!Finance - 1 days ago
Dutch Ambassador André Haspels presents Merck with 2022 Holland on the Hill Heineken Award Presentation of 2022 Holland on the Hill Heineken Award Ambassador Haspels presents the Holland on the Hill ...See details»
Don’t Miss Out on this Buy-In Window for Merck & Co. Inc. (MRK)
Source from : investchronicle - 10 days ago
Let’s start up with the current stock price of Merck & Co. Inc. (MRK), which is $87.64 to be very precise. The Stock rose vividly during the last session to $88.06 after opening rate of $87.50 while ...See details»
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck, and Glaxo
Source from : Nasdaq - 18 hours ago
The stock has declined 7.6% this year so far. Merck: Merck has a Zacks Rank of 3. The company boasts more than six blockbuster drugs in its portfolio with the PD-L1 inhibitor, Keytruda, approved for ...See details»
Merck Animal Health Donates $500,000 to Texas A&M for New Animal Science Reproduction and Biotechnology Center
Source from : Hoard's Dairyman - 1 days ago
Merck Animal Health announced a $500,000 donation to Texas A&M University for its new Animal Science Reproduction and Biotechnology Center.See details»
Merck Gets CHMP Backing for Expanded Keytruda Use in Melanoma >MRK
Source from : MarketWatch - 20 hours ago
By Colin Kellaher Merck & Co. on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended expanded ...See details»
Merck & Co Whale Trades For May 18
Source from : Benzinga.com - 2 days ago
Someone with a lot of money to spend has taken a bearish stance on Merck & Co (NYSE:MRK). And retail traders should know. We noticed this today when the big position showed up on publicly available ...See details»
Merck Animal Health Donates $250,000 to Iowa State University for New Veterinary Diagnostic Laboratory
Source from : Hoard's Dairyman - 1 days ago
Merck Animal Health, announced a $250,000 donation to Iowa State University for a new Veterinary Diagnostic Laboratory ...See details»
Anti-Arrhythmic Drug Market Analysis, Research Study With Novartis AG, Merck and Co., Inc.
Source from : Digital Journal - 1 days ago
New Jersey, United States - Research Cognizance announces the release of the Anti-Arrhythmic Drug Market research report. This study is one of the most ...See details»